Quick Answer
CytomX Therapeutics, Inc. reported Total Assets of $151.57 million for fiscal year 2025.
CytomX Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $151.57M | +25.7% |
| 2024 | $120.53M | -40.3% |
| 2023 | $201.79M | -22.7% |
| 2022 | $260.89M | -23.1% |
| 2021 | $339.41M | -5.4% |
| 2020 | $358.66M | +5.1% |
| 2019 | $341.28M | -25.3% |
| 2018 | $457.11M | +15.0% |
| 2017 | $397.64M | +99.7% |
| 2016 | $199.13M | +1.0% |
| 2015 | $197.22M | +169.9% |
| 2014 | $73.06M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $158.25M | +13.9% | -9.6% |
| June 30, 2025 | $175.06M | +9.9% | +77.7% |
| March 31, 2025 | $98.50M | -46.7% | -18.3% |
| December 31, 2024 | $120.53M | -40.3% | -13.3% |
| September 30, 2024 | $138.98M | -37.2% | -12.7% |
| June 30, 2024 | $159.22M | -23.9% | -13.8% |
| March 31, 2024 | $184.69M | -21.3% | -8.5% |
| December 31, 2023 | $201.79M | -22.7% | -8.8% |
- CytomX Therapeutics, Inc. showed an increase of +25.7% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, CytomX Therapeutics, Inc.’s total assets has grown by 107.4% (from $73.06 million to $151.57 million).
- The most recent figure is from CytomX Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: